Poland· PL-100444863
Aldactone
A potassium canrenoate product containing kalii canrenoas, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Potassium canrenoate is registered in 9 of 19 countries.
Countries holding a registration under ATC C03DA02 (potassium canrenoate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Potassium canrenoate · ATC C03DA02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of potassium canrenoate costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Potassium canrenoate · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- IT Italy$0.82
The record
At a glance
URPL (Poland)- Active substance
- Kalii canrenoas
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C03DA02
- ATC class
- Potassium canrenoate
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991445133
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for potassium canrenoate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Potassium canrenoate · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Potassium canrenoate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cde287e2-b32d-4090-8e68-db574d80c8c0 GET /v1/drugs/cde287e2-b32d-4090-8e68-db574d80c8c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "20 mg/ml",
"packaging": "05909991445133 ¦ Rp ¦ 138747\n10 amp. 10 ml",
"substance": "Kalii canrenoas 20 mg/ml",
"common_name": "Kalii canrenoas",
"pl_product_id": "100444863",
"pozwolenie_nr": "5/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-01-07"
}See everything about potassium canrenoate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.